{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-PRIME/4536",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# SANTEN PHARMACEUTICAL CO.,LTD. (Prime Market: 4536) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is SANTEN PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4536. Its ISIN is JP3336000009 and its LEI is 529900TPT3I7C17MIM03. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 11 filings on 8 filing days in the window 2025-11-06 to 2026-11-06. The filings are 3 ad hoc, 2 corporate news, 1 prospectus, 3 regulatory filing and 2 results. The median gap between filing days is 31 days. The latest filing is dated 2026-10-27 and is of type ad hoc, which is 10 days before the record date of 2026-11-06, a latency of 10 days. The Prime Market median is 10 filings, a cadence gap of 29.0 days and a latency of 70.0 days, across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a cadence gap of 49.5 days and a latency of 85.0 days, across 80 issuers. The issuer's filings are above the exchange median in count and below it in cadence gap and latency; it is above the sector median in count and below it in cadence gap and latency.\n\n## Auditor\n\nThe auditor of record is 有限責任 あずさ監査法人, whose location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the index does not carry a lifecycle type for this market. The issuer is listed and not halted.\n\n## Orderability\n\nFor the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 10 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; JPMorgan Securities Japan Co., Ltd.; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; SMBC Nikko Securities Inc.; Tokai Tokyo Intelligence Laboratory Co., Ltd.; and UBS AG.\n\n## Open research\n\nNo openly published research notes were found for the issuer.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is held for the market, and the live record began on a date not on the record.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4536 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YDH1 (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.santen.com/en/ir/stock/analyst (coverage)\n- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4536 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YDH1",
    "state": "sourced",
    "value": "有限責任 あずさ監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-PRIME/4536",
  "coverage": {
   "count": 10,
   "houses": [
    {
     "analyst": "Koichi Mamegano",
     "house": "BofA Securities Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Hidemaru Yamaguchi",
     "house": "Citigroup Global Markets Japan Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Kazuaki Hashiguchi",
     "house": "Daiwa Securities Co. Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Akinori Ueda",
     "house": "Goldman Sachs Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Seiji Wakao",
     "house": "JPMorgan Securities Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Hiroshi Tanaka",
     "house": "Mizuho Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Jaeheon Lee, Shinichiro Muraoka",
     "house": "Morgan Stanley MUFG Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Hiroshi Wada",
     "house": "SMBC Nikko Securities Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Takashi Akahane",
     "house": "Tokai Tokyo Intelligence Laboratory Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Atsushi Seki",
     "house": "UBS AG",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.santen.com/en/ir/stock/analyst",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.santen.com/en/ir/stock/analyst",
     "result": "read: 10 of 20 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1557,
     "median_cadence_gap_days": 29,
     "median_filings": 10,
     "median_latency_days": 70,
     "name": "Prime Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 3,
    "corporate_news": 2,
    "prospectus": 1,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 31,
   "filing_days": 8,
   "filings": 11,
   "latency_days": 10,
   "latest": [
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-10-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100ZA45",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "有価証券届出書 (securities registration statement)",
     "date": "2026-09-03",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Z0BR",
     "title": "有価証券届出書（参照方式）",
     "type": "prospectus"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-06-24",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YJ1Q",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-06-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHII",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "135",
     "date": "2026-06-18",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YDI9",
     "title": "確認書",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4536",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Prime Market"
   },
   "isin": {
    "read_by": "GLEIF ISIN list for the LEI (lei-records/<lei>/isins) (the one equity-pattern ISIN JP3…00x)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest (isin-lei-latest.zip, ISINs mapped to the LEI)",
    "state": "sourced",
    "value": "JP3336000009"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN JP3336000009)",
    "state": "sourced",
    "value": "529900TPT3I7C17MIM03"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "SANTEN PHARMACEUTICAL CO.,LTD."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4536"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:c6b9610438362938f6115713c25d2e00234c883c28ca54a59a5ed191249c1999",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope and the subject's record carries no instrument class to place within it",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4536",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:c6b9610438362938f6115713c25d2e00234c883c28ca54a59a5ed191249c1999",
 "path": "/jp/TSE-PRIME/4536",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is SANTEN PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4536. Its ISIN is JP3336000009 and its LEI is 529900TPT3I7C17MIM03. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 11 filings on 8 filing days in the window 2025-11-06 to 2026-11-06. The filings are 3 ad hoc, 2 corporate news, 1 prospectus, 3 regulatory filing and 2 results. The median gap between filing days is 31 days. The latest filing is dated 2026-10-27 and is of type ad hoc, which is 10 days before the record date of 2026-11-06, a latency of 10 days. The Prime Market median is 10 filings, a cadence gap of 29.0 days and a latency of 70.0 days, across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a cadence gap of 49.5 days and a latency of 85.0 days, across 80 issuers. The issuer's filings are above the exchange median in count and below it in cadence gap and latency; it is above the sector median in count and below it in cadence gap and latency.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 有限責任 あずさ監査法人, whose location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the index does not carry a lifecycle type for this market. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 10 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; JPMorgan Securities Japan Co., Ltd.; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; SMBC Nikko Securities Inc.; Tokai Tokyo Intelligence Laboratory Co., Ltd.; and UBS AG.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found for the issuer.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is held for the market, and the live record began on a date not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4536"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YDH1"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.santen.com/en/ir/stock/analyst"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4536"
  }
 ],
 "title": "SANTEN PHARMACEUTICAL CO.,LTD. (4536) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}